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Abstract
Background: The cystathionine b-synthase (CBS) gene, located on human chromosome 21q22.3, is a good candidate for
playing a role in the Down Syndrome (DS) cognitive profile: it is overexpressed in the brain of individuals with DS, and it
encodes a key enzyme of sulfur-containing amino acid (SAA) metabolism, a pathway important for several brain
physiological processes.
Methodology/Principal Findings: Here, we have studied the neural consequences of CBS overexpression in a transgenic
mouse line (60.4P102D1) expressing the human CBS gene under the control of its endogenous regulatory regions. These
mice displayed a ,2-fold increase in total CBS proteins in different brain areas and a ,1.3-fold increase in CBS activity in the
cerebellum and the hippocampus. No major disturbance of SAA metabolism was observed, and the transgenic mice
showed normal behavior in the rotarod and passive avoidance tests. However, we found that hippocampal synaptic
plasticity is facilitated in the 60.4P102D1 line.
Conclusion/Significance: We demonstrate that CBS overexpression has functional consequences on hippocampal neuronal
networks. These results shed new light on the function of the CBS gene, and raise the interesting possibility that CBS
overexpression might have an advantageous effect on some cognitive functions in DS.
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Introduction
Down syndrome (DS) is a genomic disorder, caused by total or
partial trisomy of human chromosome 21 (Hsa21), which occurs in
about 1/800 live births [1]. The clinical presentation is complex,
with more than 80 clinical features being described [2].
Penetrance and expressivity of DS phenotypic traits are highly
variable in affected people. Intellectual disability (ID) is one of the
few phenotypes with full penetrance, although its intensity can
vary from severe to moderate (IQ=25–55) [3]. Neuropsycholog-
ical examination of persons with DS has indicated particular
impairment in motor skills, language, verbal short term memory
and in explicit long-term memory, a hippocampally mediated
memory [4,5].
Although the main genetic aetiology of DS is known, i.e. an
extra copy of some Hsa21 material, much remains to be learnt
about the molecular processes involved in the pathogenesis of the
disorder. More than 400 genes have been assigned to Hsa21
(NCBI genome build 37.1). High throughput gene expression
studies have demonstrated an increase in Hsa21 gene expression
as a primary gene dosage effect [6,7,8,9,10], but the analysis of
samples with high statistical power has also indicated that only a
limited number of Hsa21 genes are significantly overexpressed,
therefore suggesting a prominent role of those dosage-sensitive
genes in the DS phenotype [6,10].
In order to understand which dosage-sensitive genes contribute
to the DS cognitive defects, mouse model approaches have been
used. Hsa21 is syntenic to genomic regions located on mouse
chromosomes 10, 16 and 17 (Mmu10, Mmu16 and Mmu17)
(www.ensembl.org). Mice with segmental trisomy of those
chromosome regions were generated [11,12,13,14,15,16], which
culminated in a mouse model bearing triplicated regions for all
human chromosome 21 syntenic regions [17]. Behavioral and
neurophysiological characterization of those models pointed to the
involvement of the Mmu16 and Mmu17 regions orthologous to
Hsa21 in cognitive function (see [18,19] for review). However,
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ing that the neurobiological phenotype results from the interaction
of several genes or regions which can have either negative or
positive effects on learning and memory and behavior. As a
complementary approach, it is thus important to investigate the
contribution of individual genes.
The Hsa21 CBS gene coding for the cystathionine b-synthase
enzyme (EC 4.2.1.22), which has a mouse orthologue on Mmu17,
is likely to be relevant to the DS cognitive profile. It belongs to the
family of Hsa21 genes that are overexpressed in the brain of DS
patients, with a 1.8-fold increase at the mRNA level in dorsolateral
prefrontal cortex [8], and a ,2.3–2.9-fold increase at the protein
level in frontal lobes [20]. CBS is involved in sulfur-containing
amino acid (SAA) metabolism (fig. 1), catalysing the the first step in
the transsulfuration pathway, where the b-replacement of L-serine
with L-homocysteine leads to the formation of cystathionine and
water [21]. CBS can catalyse an alternative b-replacement
reaction, where cysteine is used in place of serine, resulting in
the formation of cystathionine and H2S [22]. Imbalance in SAA
metabolism has been reported in individuals with DS [23,24,25].
CBS has initially been characterised as a hepatic enzyme
[26,27], but clues have accumulated indicating a role in brain
function. CBS protein is present in all cerebral regions [28,29],
and in mouse, it has been shown that Cbs gene expression is highly
regulated during the development of the central nervous system
[29,30]. The transsulfuration pathway diverts homocysteine from
the methionine cycle, and leads to cysteine formation. Albeit
initially subject to controversy, the existence of a functional
transsulfuration pathway in brain has now been established [31].
Moreover, several metabolite compounds from SAA metabolism
play important brain cellular functions: S-adenosylmethionine
(SAM) is a methyl donor, involved in neurotransmitter synthesis
[32]; glutathione and taurine are cellular redox-controlling
molecules [33,34], and H2S plays a role in synaptic plasticity
and neuroprotection [35].
A first transgenic mouse model containing the human CBS
cDNA under control of the zinc-inducible metallothionein
promoter (MT-I) has been created [36]. This model did express
the human CBS protein, but not in the brain, due to the tissue
specificity of the MT-I promoter. Three other transgenic lines
have been produced (KB2007G4, P102D1, 60.4P102D1), bearing
different human genomic fragments encompassing the CBS gene
[37]. Initial RT-PCR analysis experiments have shown expression
of the human CBS mRNA in the brain of these transgenic mice
[37]. The 60.4P102D1 line, which contains only the CBS gene, is
potentially useful for the analysis of the consequences of the
function of an extra copy of CBS in the absence of expression of
other human transgenes. However, previous work did not assess
the quantitative levels of CBS expression nor whether and to what
extent total CBS activity was altered in these mice. Here, we have
further characterized the 60.4P102D1 line. We showed that this
line of transgenic mice indeed expresses human CBS protein in the
brain, and performed quantitative analysis of CBS expression and
activity in different brain areas of the transgenic mice. We also
determined the consequences of CBS overexpression on brain
amino acid metabolism as well as on hippocampal synaptic
plasticity. We finally tested the transgenic mice for two behavioral
tasks related to cerebellar and hippocampal functions.
Results
Transgene copy number in the CBS 60.4P102D1
transgenic line
FISH analysis of the 60.4P102D1 transgenic line showed a
single insertion site, on a chromosome different from the mouse
chromosome 17, the location of the endogenous mouse Cbs gene
[37]. However, the number of copies of the CBS gene that
integrated at that site was not determined. We therefore
determined the number of in situ copies of the human CBS
transgene in hemizygous transgenic mice (referred to here as
TghCBS60.4 mice) by quantitative PCR using human DNA as a
calibrator. Human specific CBS primers were used for detection of
total copy number, and primers for both human SIM2 and mouse
Sim2 for normalization. The fold change in copy number of the
CBS gene in the hemizygous transgenic samples relative to the
human sample used as a calibrator was evaluated by the 2
2DDCt
method [38]. We found a mean value of 1.0260.03, indicating
that 2 copies of the CBS-bearing human genomic fragment were
integrated in the 60.4P102D1 line.
CBS protein expression profile in TghCBS60.4 and control
mice
The human CBS gene encodes a 551 amino-acid protein that
shares 84% identity with the 547 amino-acids encoded by its
murine counterpart. We used an anti-human CBS specific
antibody (anti-NH2hCBS) to examine the production of a
translated protein from the transgene in various TghCBS60.4
mouse tissues. We detected the expected 63-kDa polypeptide [39]
in the brain and lung of transgenic animals but found almost no
immunoreactivity in liver or kidney extracts (fig. 2A). As this
polypeptide migrated slightly faster than the human protein
detected in cultured human fibroblasts, we assessed the integrity of
the CBS transgene coding sequence. Sequencing of human specific
RT-PCR products from TghCBS60.4 brain tissue showed that the
cDNA produced from the transgene encoded the predicted 551
amino acid human CBS protein (data not shown).
We next compared the expression profile of the human protein
with the expression profile of the endogenous protein in control
mouse tissues. Immunodetection of the mouse CBS was performed
with an antibody that can recognize both the human and mouse
CBS protein (anti-hCBS) (fig. 2B). The immunoblot showed that
endogenous CBS was highly expressed in liver and kidney,
moderately in brain, and not detected in lung, as previously
described [40]. In brain, it was most highly expressed in
cerebellum, followed by hippocampus, and lastly by forebrain.
Figure 1. Involvement of CBS in sulfur-containing amino acid
metabolism. From Stipanuk [54].
doi:10.1371/journal.pone.0029056.g001
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protein in TghCBS60.4 mice (fig. 2A).
Increase in CBS expression and activity in different brain
regions of TghCBS60.4 mice
We next compared the total CBS (mouse CBS plus human
CBS) protein level in different brain regions of transgenic and
control mice. A significant increase was found in cerebellum
(,2.1-fold), forebrain (,1.8-fold) and hippocampus (,1.6-fold) of
transgenic mice (fig. 3A).
In order to determine if CBS overexpression in the TghCBS60.4
mice resulted in an increase in enzyme activity in the different
brain regions, we measured CBS activity in extracts using the
standard b-replacement reaction assay, i.e. the formation of
cystathionine from serine and homocysteine. In cerebellum and
hippocampus of transgenic mice (fig. 3B, left and middle panel),
we found that the mean activity was significantly enhanced
compared to controls (62.364.5 nmoles cystathionine/mg pro-
tein/hr vs. 43.065.0 nmoles cystathionine/mg protein/hr
and 82.260.5 nmoles cystathionine/mg protein/hr vs.
65.360.06 nmoles cystathionine/mg protein/hr, respectively).
CBS overexpression therefore resulted in a ,1.3–1.4-fold increase
in CBS activity in those brain regions. Surprisingly, no increase
in activity was found in the forebrain of transgenic mice
(56.862.0 nmoles cystathionine/mg protein/hr vs. 52.561.5
nmoles cystathionine/mg protein/hr for control mice; fig. 3B,
right panel). Altogether, these experiments demonstrate that the
60.4P102D1 mouse line is a valid model in which to assess the
functional consequences of CBS overexpression in brain. There-
fore, we undertook the analysis of these consequences.
Metabolic profiling of TghCBS60.4 mice brain
We next examined the effect of CBS overexpression on sulfur
amino-acid metabolism and other metabolic compounds in the
brain of transgenic mice. As the highest fold increase in total CBS
proteins and CBS activity was observed in the cerebellum of
transgenic animals, we used this region to determine the
concentration of 30 different amino acids and metabolite
compounds in transgenic and control mice. No statistical
difference was found for any metabolite compound under analysis
and the Tg/Control ratio for each amino acid ranged from 0.89–
1.27 (table 1). However, the level of cystathionine, the immediate
downstream product of CBS, was slightly increased in transgenic
mice, with Tg/Control ratio of 1.27 (p=0.06). The homocysteine
concentration was below detectable levels in our analysis. We also
examined amino acid levels related to SAA metabolism in the
hippocampi of transgenic and control animals, but the small
quantities of material required us to pool the hippocampi of each
group together for analysis. We found very similar ratios for all the
metabolites tested, although the largest difference in ratio (1.18)
was again observed for cystathionine (table S1).
Altered long-term synaptic plasticity in TghCBS60.4 mice
To determine whether overexpression of CBS has consequences
on brain physiology, we performed a series of electrophysiological
recordings in hippocampal slices from control and transgenic
mice. In the two genotypes, electrical stimulation of glutamatergic
afferents in the CA1 stratum radiatum induced a presynaptic fiber
volley (PFV) followed by a field excitatory postsynaptic potential
(fEPSP). This postsynaptic response was blocked at the end of the
recording by the antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydro-
benzoquinoxaline-7-sulfonamide (NBQX, 10 mM) indicating the
selective activation of AMPA subtype of glutamate receptors. Both
responses increased as a function of stimulus intensity (fig. 4A).
Comparison of input/output (I/O) curves obtained with current
stimulus intensities from 500 to 900 mA showed that the fEPSP/
PFV ratio was not significantly different in slices from control and
transgenic mice (F4.76=1.06, non-significant), thus indicating that
basal synaptic strength was not altered in TghCBS60.4 mice
(fig. 4B).
We then determined whether synaptic plasticity is altered in
transgenic mice by evaluating Long Term Potentiation (LTP)
using the theta-burst stimulation paradigm (TBS, see Materials
and Methods). In slices from control mice, the conditioning
stimulation induced a short but not long-term increase in fEPSP
slope since multivariate analyses of variance did not reveal
significant differences between baseline values and fEPSP slopes
recorded from 45 to 60 min after TBS induction (F1.18=2.3, non-
significant) (fig. 5). On the contrary, a significant increase in fEPSP
slope persisted in slices from transgenic mice at the same delay
after the conditioning stimulation (F1.22=19.7, p,0.001). As a
consequence, the magnitude of LTP measured between 45 to
60 min post-TBS was significantly higher in slices from transgenic
mice (132.5%67.5% of baseline) as compared to slices from
control animals (107.5%64.5%, F1.19=0.5, p=0.02). These data
indicate that the expression of the LTP form of synaptic plasticity
was facilitated in TghCBS60.4 mice.
Behavioral analysis of TghCBS60.4 mice
We pursued the characterization of the TghCBS60.4 mice with
some behavioral studies. Visual observation did not reveal any
obvious behavioral or morphological differences between
TghCBS60.4 mice and wild-type littermates. We used two
paradigms that test a cerebellar-dependent as well as a
hippocampal-dependent type of learning. We first assessed motor
coordination, balance and motor learning ability with the rotarod
test [41,42,43]. Performance in this test relies on the integrity of
cerebellum and basal ganglia [44,45]. Transgenic mice did not
perform differently from wild type animals either in the first
session (difference between groups: F1.14=0.045, p=0.84; inter-
action group6fall number: F2.28=0.834, p=0.45) or in the second
Figure 2. Western blot analysis of CBS expression in
TghCBS60.4 and control mouse tissues. Lu=Lung, Hp=Hippo-
campus, Fb=Forebrain, Cb=Cerebellum, Li=Liver, K=Kidney. (A) The
human 63-kDa CBS protein (HsCBS) was detected using the anti-
NH2hCBS polyclonal antibody. Human specificity of the antibody was
assessed by the absence of immunoreactivity with control mouse
tissues (liver and forebrain) and immunoreactivity with cultured human
fibroblasts (HsFi). (B) The mouse 63-kDa CBS protein (MmCBS) was
detected using the anti-hCBS polyclonal antibody. Coomassie blue
staining was used as a loading control (Figure S1).
doi:10.1371/journal.pone.0029056.g002
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action group6fall number: F2.28=0.303, p=0.74) (fig. 6A),
indicating no alteration in their motor coordination and balance.
TghCBS60.4 mice were further tested for passive avoidance, a
fear-motivated hippocampus-dependent learning task [46,47,48].
The latency to enter into the dark compartment (fig. 6B)
was not significantly different between groups in the
acquisition session (U=29.0, p=0.75) and in the reten-
tion session (U=26.0, p=0.53). This result shows that the learning
skills of the TghCBS60.4 mice measured by this task were unchanged
compared to controls.
Discussion
In an attempt to understand the contribution of some dosage-
sensitive genes in the DS brain, animal models overexpressing
individual genes have been created. These models have helped in
deciphering the function of those particular genes as well as
highlighting the molecular pathways altered after gene imbalance
[49]. Most candidate genes studied belong to the HSA21 region
orthologous to MMU16 or MMU10. The contribution of
individual genes of HSA21 orthologous to MMU17 has been less
explored. The cystathionine b-synthase gene is on MMU17. It
encodes an enzyme, which lies at a branch point for remethylation
and transsulfuration in the sulfur-containing amino acid metab-
olism. This metabolic pathway furnishes cells with compounds
involved in brain function [35,50,51]. Butler et al. [37] have
reported a transgenic mouse line expressing the human CBS gene
under the control of its own promoter (60.4P102D1). Here, we
have performed further phenotypical characterization of this line.
For the 60.4P102D1 mouse line to be a valid model to study the
consequences of CBS overexpression in brain, it was necessary to
show that transgene expression leads to an effective protein
production, and to determine the level of overexpression, since
previous studies only demonstrated expression of CBS mRNA at
an undetermined level [37]. We have shown that 60.4P102D1
mice do produce a human CBS protein in brain, and that the
human protein levels vary according to brain regions, with a
profile mimicking the endogenous one. The highest expression for
the transgenic and endogenous protein was found in cerebellum,
Figure 3. CBS expression and activity in brain regions of TghCBS60.4 mice. (A, top) Immunoblots for CBS and b-actin in cerebellum (left
panel), hippocampus (middle panel) and forebrain (right panel). Total CBS proteins (human CBS plus mouse CBS) were detected using the anti-hCBS
polyclonal antibody that recognises both the human and mouse proteins. (A, bottom) Quantification of CBS proteins normalized to b-actin and
relative to control mice in the three brain regions (n=3TghCBS60.4 and n=3 control) (B) CBS activity in cerebellum (left panel), hippocampus (middle
panel) and forebrain (right panel). Units are nanomoles of cystathionine formed per milligram of protein extract per hour. For cerebellum and
forebrain, data represent mean 6 S.E.M. of activity measurements in each group (n=9TghCBS60.4 and n=7 control; n=8 TghCBS60.4 and n=8
control, respectively). For hippocampus, data represent mean 6 S.E.M. of three experimental assays performed on same pooled hippocampi (n=7
TghCBS60.4 and n=8 control). *for p,0.05. ***for p,0.001.
doi:10.1371/journal.pone.0029056.g003
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analysis previously published [40]. We have also shown that the
integrated two copies of the human transgene in hemizygous
60.4P102D1 mice results in the expected ,2-fold increase in total
CBS proteins in the different brain areas of transgenic animals
when compared to controls. This increase is near the 2.3–2.9-fold
increase in CBS protein levels estimated in the brain of individuals
with DS [20]. Taken together, these results indicate that this
mouse line meets the criteria that are required to assess functional
consequences of CBS overexpression.
We then measured the enzymatic activity resulting from CBS
overexpression in the brain of transgenic mice. Interestingly, we
found a significant increase in cerebellum and hippocampus, but
not in forebrain. The activity was increased by ,1.3–1.4 times,
which is lower than what we found at the protein level. Disruption
of a single Cbs allele (Cbs
+/2) also resulted in a change in CBS
activity that did not match the amplitude of the change at the
protein level [52]. As for the TghCBS60.4 overexpressing mice, the
level of activity in Cbs
+/2 mice was driven towards the value of
controls, while the protein level conformed to the ploidy. These
data suggest that post-translational mechanisms of CBS regulation
are used in the mouse brain when Cbs ploidy is disturbed. Indeed,
multiple layers of CBS regulation have been described [53,54].
Unfortunately, there are no data about CBS activity in the brain of
individuals with DS, and it would be interesting to know if such
compensatory mechanisms are also present in human brain.
Quantitative analysis of 30 amine-containing metabolic com-
pounds in the cerebellum of transgenic animals did not reveal any
major metabolic disturbance due to CBS overexpression, and in
particular no main alteration of sulfur-containing amino acid
metabolism. We found however, a trend towards a slight increase
in cystathionine levels, which is consistent with an increase in flux
of homocysteine through the transsulfuration pathway, as
expected after elevating CBS activity. Likewise, a limited
metabolic profiling of the hippocampus of transgenic animals
did not reveal any major disturbance. Lack of any important
Table 1. Concentrations (nmoles/mg protein) of 30 amino acids and metabolite compounds in cerebellum extracts of TghCBS60.4
and control mice.
Control (n=7) TghCBS60.4 (n=7) Ratio Tg/Control p-value
Taurine 151.1767.17 167.1064.88 1.11 0.09
Phosphoethanolamine 18.860.92 19.2360.95 1.02 0.75
Thr 11.4560.73 14.3561.61 1.25 0.13
Ser 13.7260.53 15.7561.11 1.15 0.12
Asn 3.2860.16 3.4960.20 1.06 0.44
Glu 220.28612.5 239.2868.29 1.09 0.23
Gln 158.0868.21 162.7267.66 1.03 0.69
Sarcosine 3.3660.2 3.3460.13 0.99 0.92
a-aminoadipic acid 1.260.08 1.1460.07 0.96 0.64
Gly 65.0763.27 68.3862.65 1.05 0.45
Ala 20.5662.4 24.4762.18 1.19 0.25
Citrulline 0.6160.05 0.6960.04 1.15 0.21
Val 2.0560.08 2.2960.27 1.12 0.80
Met 1.3960.10 1.3960.12 1 0.99
Cystathionine 8.1060.36 10.2760.94 1.27 0.06
Ile 0.9560.22 0.8460.04 0.89 0.8
Leu 2.0260.15 2.0160.08 0.99 0.95
Tyr 1.8160.15 1.7660.13 0.97 1
b-Alanine 0.7760.05 0.7960.04 1.02 0.78
Phe 1.4860.08 1.5060.04 1.01 0.82
c-aminobutyric acid 58.2762.19 57.0761.7 0.98 0.67
Ethanolamine 5.8660.56 5.8760.59 1.00 0.38
Ammonia 30.3962.75 32.9562.52 1.08 0.51
Ornithine 0.1660.02 0.1960.02 1.18 0.25
Lys 3.2560.24 3.1560.14 0.97 0.72
His 1.5160.08 1.5760.07 1.03 0.63
Carnosine 2.6760.17 2.4160.25 0.90 0.4
Arg 2.8460.18 2.8760.14 1.01 0.89
Pro 1.560.14 1.3760.07 0.92 0.44
Total cysteine 5.6960.76 6.360.74 1.11 0.57
Total homocysteine BD BD ND ND
Data correspond to mean 6 S.E.M. BD: below detection. ND: not determined.
doi:10.1371/journal.pone.0029056.t001
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metabolism pathway has also been observed in the liver of the
transgenic mice expressing human CBS under the control of the
zinc-inducible metallothionein promoter, even though CBS
activity in the liver of zinc-treated mice reached 2.2 fold the level
of untreated animals [36]. These results suggest a tight control of
sulfur-containing amino acid homeostasis in tissues of transgenic
animals.
Nevertheless, we observed that CBS overexpression has
consequences on functional properties of the hippocampal
network. Our electrophysiological data indicate that basal synaptic
transmission at schaffer-colateral-CA1 synapses is unaltered in
transgenic mice but that the expression of LTP is specifically
facilitated. Interestingly, two recently described mouse models
carrying either a triplication of the entire Mmu17 region syntenic
to Hsa21 (model Dp(17)1Yey/+) [16] or triplication of a 12 gene-
containing segment from this Mmu17 syntenic region (Abcg1-
U2af1 interval; model Ts1Yah) [12] were also shown to present an
increased hippocampal LTP. Both these mouse models are
trisomic for Cbs. The Ts1Yah mice were checked for expression
of Cbs along with the other genes trisomic in these animals and the
Cbs mRNA levels were found to be elevated. CBS protein levels
and enzyme activity in the brain of these mice were not assessed.
Nonetheless, these authors identified Cbs as one of the four genes
likely to result in facilitated learning and memory in Ts1Yah mice.
Our results, which include demonstration of increased CBS
protein and enzyme activity in brain, are the first to show that
overexpression of a CBS transgene in the absence of other
transgenes has functional consequences in the brain, and provide
strong argument that CBS is involved in the regulation of synaptic
plasticity in vivo.
Induction of hippocampal LTP requires the activation of N-
methyl-D-aspartate subtype of glutamate receptor (NMDA-R) at
post-synaptic cells followed by an influx of calcium ions, which
triggers activation of numerous signalling pathways [55]. A
challenging question raised by our result is how CBS overexpres-
sion can affect this complex mechanism. It has been demonstrated
that physiological concentration of H2S enhances NMDA-R-
mediated responses [56]. One hypothesis could therefore be that
CBS overexpression in TghCBS60.4 mice facilitates LTP by raising
the hippocampal hydrogen sulfide concentrations. However, due
to the interplay between the transsulfuration pathway and other
major cellular metabolic pathways, an alternative hypothesis has
to be considered: Indeed, a link between SAM, taurine or
glutathione levels and LTP induction has been documented
[57,58,59]. Further metabolic profiling in the hippocampus of
TghCBS60.4 mice, including SAM, glutathione and hydrogen
sulfide concentration measurement, should help in discriminating
between the two hypotheses.
LTP is now widely considered as the cellular mechanism
underlying learning and memory formation [55,60,61]. As the
results obtained in the present study indicate the involvement of
CBS in this process, we explored possible behavioral changes in the
TghCBS60.4mice.Unfortunately,wecouldnot assesshippocampal-
dependent spatial memory in these mice since the FVB/N
background on which they were generated is characterized by
retinal degeneration [62], which results in poor spatial awareness
[63]. We therefore assayed the mice for contextual learning, which
also involves the hippocampus. TghCBS60.4 mice were subjected to
passive avoidance, a contextual-fear learning paradigm. This test
did not reveal any difference between the transgenic and control
mice. However, avoidance learning also depends on amygdala,
entorhinal and parietal cortex [64], therefore we cannot exclude
that those structures could counterbalance any change caused by
alteration of hippocampal synaptic pathways.
We also investigated whether we could detect any change in
sensorimotor learning in the transgenic mice due to the cerebellar
overexpression of CBS. The rotarod test showed that CBS
overexpression had no consequences on this learning task. This
is in agreement with the rotarod result in the Ts1Yah mouse
model [12].
In conclusion, we report that the 60.4P102D1 line does
overexpress CBS in the cerebellum and hippocampus at levels
comparable to what has been estimated in the brain of DS patients
and that the overexpression does affect the neurophysiology of the
hippocampus, by facilitating LTP. While the link between the
hippocampal contextual-learning and LTP remains poorly
documented, many studies on transgenic animals have document-
ed that an enhanced LTP in CA1 correlates with better
performance in spatial learning, a subtype of explicit memory in
which the hippocampus plays a critical role [55,65]. This raises the
interesting possibility that, in the context of the DS phenotype,
CBS overexpression does not directly contribute to the spatial long
term memory deficits observed in patients, but might, instead, be
associated with an advantageous effect on cognitive function.
Materials and Methods
Mice
Experiments were carried out in accordance with the European
Communities Council Directive (86/609/EEC) regarding the care
Figure 4. Basal synaptic transmission in TghCBS60.4 mice. (A)
Superimposed sample traces of evoked AMPA-R-mediated fEPSPs
induced in a control (left) and a TghCBS60.4 mouse (right) by increased
intensities of electrical stimulation of glutamate afferents (arrow). Traces
are averages of 3 consecutive responses. (B) Comparison of synaptic
efficacy as determined by the fEPSP/PFV ratio calculated at a stimulus
intensity from 500 to 900 mAi nT g hCBS60.4 (23 slices/5 animals) and
control (22 slices/5 animals) mice.
doi:10.1371/journal.pone.0029056.g004
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approved by the Jacques Monod Institut Animal ethical committee
(CEEA-40, approval number CEB-001-2011).
First and second generation hemizygous transgenic 60.4P102D1
mice [37] were generated at the Eleanor Roosevelt Institute
Transgenic mouse facility (Denver), and subsequently bred with
wild-type FVB/N mice at the Institut Jacques Monod animal
facility (Paris). Animals were kept under a 12 h light/dark cycle
with unlimited food and water.
At 3–4 weeks of age, descendants were genotyped by PCR
analysis of tail DNA using a human-specific CBS primers as
described in Butler et al. [37]. Male mice hemizygous for the
human CBS transgene (referred to here as TghCBS60.4 mice) and
age-matched controls were compared in each experiment. For
experiments performed on tissues, mice were euthanized with CO2
and tissues were quickly removed, frozen in liquid nitrogen, and
stored at 280uC until used. Brain was dissected on ice to separate
cerebellum, hippocampus and forebrain.
Figure 5. Theta-burst-induced LTP in TghCBS60.4 mice. Comparison of averaged LTP expressed as percent change in the slope of fEPSP vs
time, induced by theta-burst stimulation (TBS, arrow) of glutamate afferents and recorded in slices from TghCBS60.4 (12 slices/9 animals) and control
(10 slices/7 animals) mice. In the insert, representative traces of fEPSPs, recorded before and 60 min after TBS, are superimposed.
doi:10.1371/journal.pone.0029056.g005
Figure 6. Behavioral assessments in TghCBS60.4 mice. The analysis was conducted on 8 TghCBS60.4 and 8 control mice. Data represent
mean+S.E.M. for each group. (A) Rotarod test: latencies of first fall, second fall and third fall recorded in the 10 min accelerating periods of the two
rotarod sessions (S1, S2) are presented. (B) Passive avoidance test: latency to enter into the dark compartment in acquisition session and in retention
session was recorded.
doi:10.1371/journal.pone.0029056.g006
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Transgene copy number in the 60.4P102D1 transgenic line was
determined using a method adapted from Ballester et al. [66].
Human-specific CBS primers (left: 59AACCTGGGAAGCTGG-
CATTG39; right: 59ATCCCACACACACGCCTGAA39) and
primers common to human SIM2 and mouse Sim2 (left:
59GCTGGACATGTCCCTGTAC39; right: 59GCTTCAGGT-
CAAGGCTGG39) were designed. The human SIM2 and mouse
Sim2 were used as reference control genes. Genomic DNA was
isolated from the tail of 3 hemizygous mice as well as from a
human lymphoblastoid cell line derived from a control individual
[6], used as a calibrator. Real time PCR was carried out on
genomic DNA using LightCycler 480 SYBR Green I Master kit
(Roche Diagnostics) with the above-mentioned primers and
LightCycler 480 as recommended by the manufacturers. For
each genomic DNA, serial dilutions were prepared (50 ng to
0.048 ng) and each dilution was run in triplicate. A plot of
log10Input DNA vs DCt (CtCBS-Ctcontrol gene) was done for each
DNA sample. Obtention of absolute slopes ,0.1 in all cases
indicated that PCR efficiencies of CBS and control genes were
approximately equal in each DNA sample (ECBS=E control gene),
thus permitting the use of the 2
2DCt method (see Applied
Biosystems user bulletin #2). The same method was used to
assess that PCR efficiencies were the same for each amplicon on
mouse or human DNA. The 2
2DDCt method was then used to
compare the DCt value of transgenic animal samples (CtCBS-
CtSim2) with unknown copy number with the DCt of human DNA
sample (CtCBS-CtSIM2). Since transgenic animals were hemizygous
for the transgene while the human calibrator was homozygous for
CBS, the transgene copy number was obtained by multiplying the
2
2DDCt value by a factor of two.
Immunoblotting
Tissues from 4 month-old mice were either directly homoge-
nized (lung, hippocampus, cerebellum, liver) or reduced to
powder with mortar and pestle before homogenization (forebrain,
kidney) in ice-cold 0.1 M sodium phosphate pH 7.2 (10 ml/mg of
tissue) containing protease inhibitor (Complete-Mini, Roche
Diagnostics). The homogenate was centrifuged at 12500 g for
10 min at 4uC and the supernatant was retained. Protein
concentration was determined using the Bio Rad Bradford
protein assay following the manufacturer’s instructions. Equal
amounts of protein (20 mg) were separated on a 10% SDS-
polyacrylamide gel and electrotransferred onto nitrocellulose
membranes (Amersham Biosciences). Antibody incubations were
done in TBST (50 mM Tris-HCl, pH 8, 150 mM NaCl and
0.5% Tween) containing 4% skimmed milk. Two different
affinity-purified polyclonal rabbit anti-human CBS antibodies
were used: anti-hCBS (1:5000; previously described in Kraus
[67]), raised against the full length human CBS protein was used
for simultaneous detection of human and mouse CBS proteins,
and anti-NH2hCBS (1:1000) raised against the synthetic peptide
(GCPASESPHHHTAPAK, Biosynthesis, Inc.) was used for
specific detection of the human CBS protein. Monoclonal anti-
b actin antibody (1:4000, clone AC-15, Sigma) was used as
loading control. Primary antibody was detected with the species-
appropriate HRP-conjugated secondary antibody (anti-rabbit
IgG, 1:2000 or anti-mouse IgG, 1:40000, Sigma). Signal was
visualized with the LAS-3000 Image reader (Fujifilm) after
treatment with western blotting luminol reagent (Santa Cruz
Biotechnology). Densitometric analyses were performed with
Science Lab 2003-Image Gauge v4.2 Software (Fujifilm). Each
experiment was repeated twice.
Cystathionine b-synthase (CBS) activity measurement
Brain tissues from 6–7 month-old mice were homogenized in
extraction buffer (10 mM Tris HCl; pH 8) containing protease
inhibitor cocktail tablet (Complete mini-Roche Diagnostics).
Homogenates were then centrifuged at 13000 rpm at 4uC and
supernatant was retained. Protein concentration in the superna-
tant was determined by Coomassie Plus Bradford assay reagent
(Pierce, Rockford, IL, USA) using BSA as a standard. Hippocampi
from animals with the same genotype (n=7TghCBS60.4 and n=8
control) were pooled together to obtain sufficient amount of tissue
for processing. CBS activity was analyzed as previously described
[36] by employing Biochrom 30 amino acid analyzer to measure
cystathionine levels. Briefly, the reaction mixture contained Na-N,
N-Bis (2-hydroxyethyl) glycine buffer (200 mM; pH 8.6), DL-
Homocysteine (10 mM), L-Serine (5 mM), pyridoxal phosphate
(50 mM) and AdoMet (250 mM). The reaction was started by the
addition of 30 mg of dialysed protein extract and CBS activity was
measured in terms of nmoles of cystathionine formed per
milligram of protein per hour at 37uC. In the case of pooled
hippocampi, CBS activity was measured in triplicate on the same
extracts in two independent experiments.
Amino acid analysis
Amino acid analysis was done by Biochrom 30 amino acid
analyzer as previously described [36]. In summary, 300 mgo f
undialysed protein extracts prepared for CBS activity measure-
ments were reduced by dithiothreitol and then treated with an
equal volume of 10% sulfosalicylic acid followed by centrifugation.
The supernatant was then analysed for amino acid content by
using the amino acid analyser. Protein concentration in the
extracts was determined by Coomassie Plus Bradford assay
reagent (Pierce, Rockford, IL, USA). Amino acids were quantified
by comparing peak area to a known standard using EZChrom
Elite software. Results are expressed as nmoles amino acid/mg
protein.
Electrophysiology
The experiments were conducted with 6–7 month-old mice.
Transverse hippocampal slices (400 mm) were obtained as
previously described [68] in mice anesthetized with halothane
before decapitation. Slices were prepared in ice-cold artificial
cerebrospinal fluid (aCSF) and placed in a holding chamber for at
least 1 hr. The composition of aCSF was as follows (in mM): NaCl
124, KCl 3.5, MgSO4 1.5, CaCl2 2.3, NaHCO3 26.2, NaH2PO4
1.2, and glucose 11, pH 7.4. A single slice was transferred to the
recording chamber at a time and continuously superfused with
aCSF pre-gassed with 95% O2/5% CO2. Extracellular recordings
were obtained at room temperature from the apical dendritic layer
of the CA1 area using micropipettes filled with 2 M NaCl.
Presynaptic fiber volleys (PFVs) and field excitatory postsynaptic
potentials (fEPSPs) were evoked by electrical stimulation of
Schaffer collaterals and commissural fibers located in the stratum
radiatum. The averaged slope of three PFVs and fEPSPs was
measured using the Win LTP software [69]. To evaluate the level
of receptor activation, the fEPSP/PFV ratio was plotted against
stimulus intensity (from 500 to 900 mA). In order to investigate
long-term potentiation (LTP) of synaptic transmission, a test
stimulus was applied every 10 sec and adjusted to get a fEPSP with
a baseline slope of 0.1 V/sec. The averaged slope of 3 fEPSPs was
measured for 15 min before theta-burst stimulation (TBS),
consisting of 5 trains of four 100 Hz pulses each, separated by
200 ms and delivered at the test intensity. This sequence was
repeated three times with an interburst interval of 10 s. Testing
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29056with a single pulse was then resumed for 60 min to determine the
level of LTP.
Behavioral assessment
Behavioral studies were done on 5–6 month-old TghCBS60.4
and wild-type littermate control male mice. Animals were first
submitted to the passive avoidance test, and they were submitted
to the rotarod test one week later.
The passive avoidance apparatus (Panlab, Bioseb, France)
consisted of two compartments separated by a guillotine door.
One compartment was brightly lit; the other compartment was
dark with a grid floor connected to an electrical scrambler. The
test consisted in an acquisition session and a retention session,
conducted 24 h apart. On the acquisition session, the animal was
placed in the lit compartment. After 30 s, the guillotine door was
opened. As soon as the animal entered the dark compartment, the
guillotine door was closed and an electric shock (0.4 mA, 0.5 s)
was delivered through the grid-floor. An animal which did not
enter into the dark compartment within 300 s after the guillotine
door was opened was discarded from the experiment. The
retention session was conducted in the same way as the acquisition
session except that the shock was not delivered if the animal
entered the dark compartment. The latency to enter into the dark
compartment was recorded in the acquisition session and in the
retention session.
Motor coordination and balancing was tested with an
accelerating rotarod (TSE systems; Bad Homburg, Germany).
The rotating rod was elevated 10 cm off the floor, had an axis
diameter of 3.5 cm and a striated surface made of black rubber.
Animals were trained to stay on the rotarod for two 11 min
sessions, conducted 24 hours apart. For each session, the animal
was placed on the rod which rotates at 1 revolution per min (rpm)
for the first min (habituation period). An animal which fell from
the rod during the habituation period was placed again on the rod;
falls occuring during this period were not taken into account in the
analysis of the performance. Then, the speed of the rod
progressively accelerated from 1 to 30 rpm (10 min accelerating
period). During the accelerating period, animals were allowed to
fall three times. They were placed again on the rod after the 1st
and 2nd fall, and removed from the apparatus after the 3rd fall.
The first, second and third fall latencies (min: 0 s - maximum:
600 s if no falls occurred) were recorded.
Data analysis
All results are expressed as mean 6 S.E.M. For statistical
analysis, group means were compared using the Student unpaired
two-tailed t-test, or the Mann-Whitney-Wilcoxon test when
variables were not normally distributed. For electrophysiology
experiments, p-values were calculated using multivariate analyses
of variance followed by post-hoc unpaired t tests, in order to take
into account the correlations inherent in repeated measures data.
Performance on the rotarod was compared using repeated
measures ANOVA with falls as repeated measures. In all cases,
differences were considered significant when the p-value#0.05.
Supporting Information
Figure S1 Coomassie blue staining of the SDS-PAGE
blotted in (A) fig. 2A and (B) fig. 2B.
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